Most Recent
BMW says court can’t make funding order in Takata class actions
Class Actions 2018-09-19 8:40 pm By Miklos Bolza

BMW Australia plans to challenge the NSW Supreme Court’s power to create a common fund order spanning six class actions brought against major players in […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Source code copyright fight settles before damages trial
Intellectual Property 2018-09-17 3:12 pm By Christine Caulfield

On the eve of a hearing into damages, rival pavement engineering companies have resolved a copyright dispute that continued important law on what constitutes infringement […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Auto giants ready to talk settlement in Takata class actions
Product Liability 2018-08-28 9:54 pm By Miklos Bolza

Six major car companies indicated Tuesday they were open to a quick settlement of class actions brought on behalf of potentially hundreds of thousands of […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Nurofen superiority claims breached consumer law, Full Court affirms
Competition & Consumer Protection 2018-08-24 11:19 am By Cat Fredenburgh

The Full Federal Court has shot down Reckitt Benckiser’s appeal of a ruling that it misled consumers with claims that its Nurofen is a more […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Judge overlooked crucial evidence in Nurofen case, Full Court hears
Competition & Consumer Protection 2018-08-20 10:23 pm By Miklos Bolza

A Federal Court judge skipped vital witness testimony when he ruled Reckitt Benckiser misled consumers about the effectiveness of its Nurofen painkiller, the pharmaceutical company […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

GSK slams ACCC’s ‘onerous’ compliance program in Voltaren case
Competition & Consumer Protection 2018-08-01 9:01 pm By Miklos Bolza

The final day of trial in the ACCC’s case over muscle gel Voltaren wrapped up Wednesday with a barrister for GlaxoSmithKline slamming as “onerous” a […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

ACCC is not GSK’s compliance department, court told
Competition & Consumer Protection 2018-07-30 8:22 pm By Miklos Bolza

The first day of a liability hearing in a consumer case over GlaxoSmithKline’s marketing for its popular Voltaren products has seen an ACCC witness deflect […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

GSK argues tube cap should cut penalties in ACCC Voltaren case
Competition & Consumer Protection 2018-06-08 9:35 pm By Miklos Bolza

GlaxoSmithKline is pushing for lower penalties in a case brought by the Australian Competition and Consumer Commission alleging the pharma giant breached the Australian Consumer […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Asiago cheese needn’t come from Italy, IP Australia rules
Intellectual Property 2018-06-05 11:13 pm By Miklos Bolza

IP Australia has ruled in part that cheese branded with the Asiago label need not be manufactured in the Asiago region in Italy, striking down an […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Wyeth says generic Effexor registration ‘not legitimate’
Intellectual Property 2018-06-05 10:14 pm By Miklos Bolza

Three generic drug manufacturers cannot claim damages for an injunction barring the release of cheaper versions of Effexor-XR, even if the injunction was later overturned, […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.